Bioinformatics Technicians
15-2099.01Median wage $81,490/yr3,720 employed (US)Rank #62 of 923 scored · top 7% by substitution
Apply principles and methods of bioinformatics to assist scientists in areas such as pharmaceuticals, medical technology, biotechnology, computational biology, proteomics, computer information science, biology and medical informatics. Apply bioinformatics tools to visualize, analyze, manipulate or interpret molecular data. May build and maintain databases for processing and analyzing genomic or other biological information.
Sub-scores
0–100 · band = confidence interval from rater disagreement
Substitution56
Exposure51
Augmentation77
Substitution — the headline: capability discounted by cost, barriers and adoption.
Exposure — technical capability alone, regardless of whether anyone deploys it.
Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.
Tasks on the substitution scale
19 rated tasks, binned by substitution score.
Position among all scored occupations
Distribution of 923 occupation scores; the marker is this occupation.
Tasks with substitution ≥ 70
16%
Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.
Why this score
The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.
Task automatabilityw 35%51
panel mean rating 3.0/5 → substitution pressure 51/100
Technical feasibility todayw 20%50
panel mean rating 3.0/5 → substitution pressure 50/100
Cost vs. human wagew 15%55
panel mean rating 3.2/5 → substitution pressure 55/100
Adoption barriersw 20%inverted — strong barriers lower the score70
panel mean rating 2.2/5 (barrier strength) → substitution pressure 70/100
Sector adoption velocityw 10%53
panel mean rating 3.1/5 → substitution pressure 53/100
Task breakdown (19 tasks)
Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.
Document all database changes, modifications, or problems.
84CI 67–100 · exposure 83 · augmentation 88 · importance 3.5/5 · click for rater detail
Document all database changes, modifications, or problems.
84| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 5/5 | Bioinformatics and genomics organizations are digitally mature, information-intensive sectors with strong adoption of automated database management, CI/CD pipelines, and audit logging; this task is already routinely automated in production environments. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Bioinformatics and life sciences organizations are adopting AI tools for documentation and coding support, but adoption is uneven and slower than in pure software/tech sectors. Pilots and partial integration are common but full production-scale reliance is not yet universal. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI can assist by auto-generating detailed summaries of complex changes, flagging anomalies, cross-referencing affected datasets, and drafting documentation—substantially raising technician productivity while preserving human review of critical modifications. |
| Augmentation potential | claude-sonnet-5 | 5/5 | AI can significantly speed up drafting of clear, consistent documentation from raw logs or notes, letting technicians review and finalize rather than write from scratch. This is a strong augmentation use case even where full automation isn't fully trusted. |
| Task automatability | claude-haiku-4-5-20251001 | 5/5 | Database change logging and documentation is highly structured and repetitive—modern systems already auto-log modifications with metadata (timestamps, user, operation type), and AI can reliably extract, contextualize, and document these changes with minimal human intervention, easily meeting the 50% time-saving threshold. |
| Task automatability | claude-sonnet-5 | 4/5 | Documenting database changes, modifications, or problems is a structured writing/logging task that current LLMs can perform well from change logs, diffs, or ticket data with minimal human editing. Most of the drafting and summarization work can be automated, though verification against actual system state may need human oversight. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Some organizations require human review and sign-off on critical database changes for compliance or audit purposes, and certain secure environments may restrict automated logging; however, most bioinformatics labs can and do automate this task without legal or regulatory mandate for human involvement. |
| Adoption barriers | claude-sonnet-5 | 1/5 | Documentation of database changes carries no licensing or liability requirements and is typically an internal administrative task with no requirement for human sign-off. Organizational friction is minimal since this is often seen as tedious record-keeping. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 5/5 | Automated logging and AI-assisted documentation cost pennies per entry and run continuously with negligible marginal expense, compared to manual review and write-up by a technician at full loaded wages—typically 100–1000× cheaper. |
| Cost vs. human wage | claude-sonnet-5 | 4/5 | Automated documentation generation via AI is very cheap compared to a technician's time spent writing logs, especially for routine, templated entries. Some oversight cost remains to ensure accuracy of technical details. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 5/5 | Automated database logging and change-tracking systems (e.g., database audit trails, version control integration, ETL monitoring tools) are mature, production-deployed products that reliably capture and document modifications in real bioinformatics environments at scale. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Products like AI-assisted changelog generators, commit-message summarizers, and IT documentation tools exist and are used, but bioinformatics-specific database documentation workflows are less standardized and often still manually maintained. Deployment in this specific niche is narrower than in general software engineering contexts. |
Enter or retrieve information from structural databases, protein sequence motif databases, mutation databases, genomic databases or gene expression databases.
82CI 72–92 · exposure 87 · augmentation 88 · importance 3.8/5 · click for rater detail
Enter or retrieve information from structural databases, protein sequence motif databases, mutation databases, genomic databases or gene expression databases.
82| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics and genomics are highly digitized, research-intensive fields with rapid adoption of automation and computational tools. Major institutions and biotech firms are already deploying automated data retrieval and query pipelines in production. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Bioinformatics as a field has adopted scripting and automation broadly, but AI-agent-driven end-to-end use in production labs is still emerging rather than fully mainstream. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI can dramatically assist humans in rapidly searching, filtering, and summarizing database results, allowing technicians to focus on interpretation and curation rather than manual data entry and retrieval. |
| Augmentation potential | claude-sonnet-5 | 5/5 | AI tools significantly speed up database searches, cross-referencing, and data retrieval, letting technicians focus on interpretation and validation. |
| Task automatability | claude-haiku-4-5-20251001 | 5/5 | Retrieving information from structured databases is a core strength of current AI systems. APIs and LLM-based agents can query, parse, and extract data from genomic and protein databases with high reliability and speed, achieving well over 50% time savings on routine information retrieval. |
| Task automatability | claude-sonnet-5 | 4/5 | Querying and entering data into structured biological databases (BLAST, UniProt, GenBank, PDB) is a well-defined, API-accessible task that AI agents can perform via scripting and tool use with substantial time savings.: |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | While some organizations have data governance and access-control policies around sensitive genetic databases, there are no hard legal or licensing barriers preventing AI automation of database queries. Most friction is organizational preference for human verification rather than regulatory requirement. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement for database queries, though data governance, quality control, and accuracy verification create moderate organizational friction. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 5/5 | The cost of AI-driven database queries and retrieval (API calls, modest compute, minimal oversight) is orders of magnitude cheaper than paying a technician's loaded wage to manually search and extract the same data. |
| Cost vs. human wage | claude-sonnet-5 | 4/5 | Automated querying/scripting is far cheaper than manual technician time for routine lookups and data entry, though initial pipeline setup and occasional oversight add some cost. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 5/5 | Multiple mature products and deployed systems (e.g., automated bioinformatics pipelines, LLM-backed database query agents, bioinformatics APIs) reliably perform database queries and data retrieval at scale in research and clinical settings today. |
| Technical feasibility today | claude-sonnet-5 | 4/5 | Production tools already exist (Biopython pipelines, LLM-driven bioinformatics agents, database APIs) that reliably retrieve and enter records, though complex curation or ambiguous entries still need human review. |
Write computer programs or scripts to be used in querying databases.
79CI 75–84 · exposure 75 · augmentation 100 · importance 3.5/5 · click for rater detail
Write computer programs or scripts to be used in querying databases.
79| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics and IT sectors show strong adoption of AI coding assistants, with widespread pilot and production use of tools like Copilot in academic and pharmaceutical research settings. Information and life-science sectors are among the fastest adopters of generative AI. |
| Sector adoption velocity | claude-sonnet-5 | 4/5 | Software development and bioinformatics/life sciences research have seen fast adoption of AI coding assistants, though full lab environments vary in maturity and integration. |
| Augmentation potential | claude-haiku-4-5-20251001 | 5/5 | AI code assistants powerfully augment bioinformatics technicians by auto-completing queries, suggesting syntax, and reducing boilerplate—allowing the human to focus on logic and domain requirements while staying fully in the loop to validate and refine output. |
| Augmentation potential | claude-sonnet-5 | 5/5 | AI coding assistants substantially speed up writing, debugging, and documenting scripts while the technician retains oversight of correctness and domain-specific logic. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Current AI systems (e.g., GitHub Copilot, Claude, ChatGPT) can automatically generate database query scripts with minimal human input, often meeting or exceeding 50% time savings for routine queries. However, complex domain-specific requirements or edge cases may still require human review and refinement. |
| Task automatability | claude-sonnet-5 | 4/5 | Writing scripts to query databases (e.g., SQL, Biopython, REST API calls) is a well-scoped coding task that current LLMs handle very well, especially with iterative debugging support, meeting the time-saving threshold for most routine cases. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | There are minimal legal or regulatory barriers to automating script generation itself; no licensing requirement mandates human authorship. Organizational friction and code review processes provide some friction, but these are soft barriers rather than hard blockers. |
| Adoption barriers | claude-sonnet-5 | 1/5 | There is no licensing, regulatory, or liability barrier to using AI-assisted tools for writing database query scripts; it is standard practice already. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | API-based code generation costs (pennies to dollars per task) are substantially lower than loaded technician wages ($25–35/hour), making AI roughly 10–100× cheaper per script generated when accounting for integration and oversight. |
| Cost vs. human wage | claude-sonnet-5 | 5/5 | AI-assisted script generation costs a fraction of a cent to a few dollars in inference versus the loaded hourly wage of a technician, representing an order-of-magnitude cost advantage for routine scripting. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Multiple production systems (GitHub Copilot, cloud-based code assistants, LLMs with code generation) reliably generate database query scripts used in real organizations. Error rates are low for standard queries, though complex or highly specialized bioinformatics queries may have higher failure rates requiring oversight. |
| Technical feasibility today | claude-sonnet-5 | 4/5 | Deployed coding assistants (Copilot, Claude, ChatGPT) are widely used in bioinformatics for writing query scripts against databases like NCBI, Ensembl, or internal LIMS, though complex schema-specific or novel pipeline work still requires human review. |
Package bioinformatics data for submission to public repositories.
67CI 67–67 · exposure 66 · augmentation 75 · importance 3.3/5 · click for rater detail
Package bioinformatics data for submission to public repositories.
67| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 3/5 | Bioinformatics is digitized and research-oriented, favoring automation adoption, but actual deployment of AI agents for data packaging remains in the pilot and early production phase; most institutions still rely on manual or semi-automated workflows. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Life sciences and bioinformatics are increasingly adopting automation and AI pipelines, but adoption is uneven across labs and institutions, with many still using manual or semi-automated workflows. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI can assist technicians by auto-generating formatted metadata, suggesting corrections, and validating against repository schemas in real time, significantly accelerating the packaging process while the human maintains oversight and quality control. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI and scripting tools substantially speed up metadata formatting, validation, and error-checking, letting technicians focus on data quality and edge cases rather than repetitive formatting work. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Most of this task—formatting data according to repository schemas, validating file structures, organizing metadata—can be automated with high-quality outputs using current AI and scripting tools. Some domain judgment (e.g., verifying biological accuracy of annotations) may remain, but the bulk of the packaging workflow meets the ≥50% time-saving threshold. |
| Task automatability | claude-sonnet-5 | 4/5 | Formatting and packaging data for repositories like GenBank or SRA follows well-defined schemas and metadata standards that scripts and AI tools can largely automate, though some validation and edge-case handling remain. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | No licensing requirement or legal mandate for human sign-off exists; repositories have technical submission requirements but not regulatory bars to automation. Some institutions prefer human review for quality assurance, but this is organizational friction rather than a hard barrier. |
| Adoption barriers | claude-sonnet-5 | 2/5 | There are some data standards and compliance requirements (e.g., repository-specific metadata rules, data privacy for human subject data) but no licensing requirement mandating a credentialed human perform this task. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Automating packaging via scripts and AI inference is substantially cheaper than paying a technician's loaded wage per submission cycle, especially at scale. Integration and maintenance costs are modest relative to labor savings. |
| Cost vs. human wage | claude-sonnet-5 | 4/5 | Once configured, automated scripts and AI-assisted metadata tools can process and package data at a fraction of the cost of manual technician labor, though initial setup and validation require human oversight. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Tools and scripts exist for data formatting and validation (including some AI-assisted parsing), and they are used in production at research institutions and core facilities. However, error rates remain material for complex or non-standard datasets, and integration with specific repository APIs requires ongoing oversight. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Bioinformatics pipelines and submission tools (e.g., NCBI's submission portals, automated metadata generators) exist and are used, but many labs still rely on manual checks and custom scripting rather than fully mature AI-driven products. |
Analyze or manipulate bioinformatics data using software packages, statistical applications, or data mining techniques.
65CI 55–75 · exposure 62 · augmentation 75 · importance 4.0/5 · click for rater detail
Analyze or manipulate bioinformatics data using software packages, statistical applications, or data mining techniques.
65| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Life sciences, biotech, and pharmaceutical sectors—where this task concentrates—are digitally mature and actively adopting automated pipelines, cloud platforms (AWS, Azure), and ML-driven genomics tools; academic and commercial labs widely deploy CI/CD-style automation for routine analyses. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Life sciences and bioinformatics are adopting AI-assisted coding and analysis tools at a moderate pace, with pilots and partial integration common but full agentic pipelines not yet dominant. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI tools (statistical packages, visualization frameworks, predictive models, and data wrangling assistants) significantly amplify technician productivity by automating routine steps, generating hypotheses, and flagging anomalies while the technician retains interpretive control and experimental judgment. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI substantially boosts productivity by generating analysis code, suggesting statistical approaches, and summarizing outputs, while the technician remains essential for validation and domain-specific judgment. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Most of the analytical pipeline—data preprocessing, statistical testing, pattern discovery via machine learning—can be automated with existing tools and scripts; however, bioinformatics interpretation, quality assurance decisions, and experimental design choices often require domain expertise, preventing full 50%-time-saving automation without human oversight. |
| Task automatability | claude-sonnet-5 | 3/5 | AI can perform many routine data manipulation, statistical, and scripting subtasks (e.g., writing analysis pipelines, running standard bioinformatics tools) but complex experimental design, quality judgment, and novel biological interpretation still require human expertise, limiting full end-to-end automation. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Bioinformatics analysis is not legally gated; however, organizations often require bioinformatician sign-off on results, and data privacy regulations (HIPAA, GDPR) create modest friction when moving sensitive genomic or clinical data to cloud systems, but these are policy, not legal blocking barriers. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No formal licensing requirement blocks AI use in bioinformatics analysis, though data governance, reproducibility standards, and error-cost concerns in research/clinical contexts create some friction. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Cloud-based bioinformatics tools and open-source software have negligible per-run costs compared to technician labor (~$20–50/hour loaded); infrastructure and oversight costs are moderate, making AI-driven automation substantially cheaper than human technicians for routine analysis tasks. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | AI tools reduce time spent on coding and routine analysis, but human review, domain expertise, and computational infrastructure costs keep the overall cost roughly comparable to or moderately cheaper than a technician's labor. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Mature bioinformatics platforms (Galaxy, GATK, DESeq2, scikit-learn, commercial pipelines) reliably perform data manipulation and statistical analysis in production; however, the heterogeneity of data formats, the need for custom parameter tuning, and the requirement for domain-driven validation create pockets of brittleness that limit production reliability in novel contexts. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Coding assistants and AI-augmented notebooks are used in production for scripting and routine analysis, but fully autonomous, reliable execution of complex bioinformatics pipelines without human oversight is not yet standard practice. |
Conduct quality analyses of data inputs and resulting analyses or predictions.
65CI 55–75 · exposure 62 · augmentation 75 · importance 3.8/5 · click for rater detail
Conduct quality analyses of data inputs and resulting analyses or predictions.
65| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics and life sciences are information-intensive, digitized sectors with strong adoption of automated QA tools. Major research centers, pharmaceutical firms, and sequencing labs routinely deploy automated validation pipelines, indicating rapid and deep adoption in this domain. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Genomics and computational biology labs increasingly use automated QC tools and ML anomaly detection, but adoption is uneven across academic vs. industry settings and full agentic automation is still rare. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI-driven QA systems assist technicians by flagging anomalies, generating detailed reports, and recommending corrective actions, allowing humans to focus on investigation and interpretation rather than manual checking. This significantly boosts productivity while keeping the technician in a supervisory role. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI-based QC tools substantially speed up flagging of data anomalies and generate diagnostic visualizations, meaningfully boosting technician throughput while they retain oversight of biological interpretation. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Quality analysis of bioinformatics data involves structured validation, statistical checks, and comparison against known benchmarks—tasks well-suited to automated pipelines and AI systems. Current tools can detect outliers, validate formats, flag inconsistencies, and verify predictions against ground truth with minimal human oversight, achieving substantial time savings. |
| Task automatability | claude-sonnet-5 | 3/5 | AI can automate many statistical QC checks (e.g., flagging outliers, low-coverage reads, batch effects) but interpreting biological plausibility and deciding on corrective action often still requires domain expertise.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Quality control automation in bioinformatics faces minimal legal or regulatory barriers; no licensing requirement mandates human review. However, organizational inertia (preference for human sign-off on critical data) and the need for domain expertise in configuring validation rules create moderate friction. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement for this specific QC task, though downstream clinical or regulatory use of the data may impose review requirements indirectly. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Automated QA pipelines (compute + infrastructure + occasional human review) cost far less than hiring technicians to manually validate large datasets. A single automated system can monitor thousands of analyses, making the cost per check orders of magnitude lower than human labor. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | Automated QC scripts are cheap to run repeatedly, but integration, validation, and maintaining pipelines still require paid technician/bioinformatician time, keeping costs roughly comparable for full-scope QC. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Mature products for data quality control, automated validation pipelines, and ML-based anomaly detection in bioinformatics are deployed in production at major research institutions and biotech firms. Tools like FastQC, custom validation frameworks, and statistical QA systems are standard practice, though complex interpretative edge cases may still require human judgment. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Deployed bioinformatics pipelines already include automated QC modules (e.g., FastQC, MultiQC) and ML-based anomaly detection, but these are narrow tools requiring human review, not end-to-end autonomous QC agents. |
Perform routine system administrative functions, such as troubleshooting, back-ups, or upgrades.
61CI 46–75 · exposure 55 · augmentation 75 · importance 3.4/5 · click for rater detail
Perform routine system administrative functions, such as troubleshooting, back-ups, or upgrades.
61| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics and biotech sectors are digitally mature, cloud-native environments with rapid adoption of automated DevOps, infrastructure monitoring, and maintenance tools. Industry-wide shift to managed cloud services and continuous deployment pipelines demonstrates fast, deep adoption. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | IT operations automation (DevOps, AIOps) is widely adopted in tech-forward sectors, but bioinformatics core facilities and academic labs tend to lag in adopting advanced automation for infrastructure management. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI tools effectively augment technicians by automating routine checks, suggesting fixes, and alerting to anomalies, freeing them to focus on complex troubleshooting and strategic system improvements while remaining in oversight. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI-assisted monitoring, log analysis, and automated alerting tools significantly help technicians detect and diagnose issues faster, even though human judgment remains central to resolving complex problems. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Routine system administration tasks like backups, updates, and standard troubleshooting are highly scriptable and automatable. Current AI agents with tool access can handle many of these workflows end-to-end, though some complex troubleshooting may require human oversight, meeting or approaching the ≥50% time-saving threshold. |
| Task automatability | claude-sonnet-5 | 2/5 | Routine sysadmin tasks like backups and upgrades can be scripted/automated, but troubleshooting unpredictable failures in specialized bioinformatics systems still requires human diagnosis and hands-on intervention, limiting full end-to-end automation. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Few regulatory or licensure barriers exist for system administration automation in typical bioinformatics settings. Organizational friction and the desire for human oversight of critical systems provide some resistance, but these are not hard legal or contractual blockers. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement for sysadmin work, though data security and compliance considerations in research/clinical settings add some institutional oversight before fully removing human involvement. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Automated backup, patch management, and monitoring solutions are commodity offerings with per-instance or subscription costs far below technician labor. AI oversight is minimal for routine tasks, making the cost advantage substantial—several multiples below human wages. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | Automated backup/monitoring tools are cheap and common, but troubleshooting complex or novel system issues still requires paid technician time, keeping overall cost roughly comparable to human labor for the full task scope. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Deployed products like cloud management platforms, infrastructure-as-code tools, and AI-assisted monitoring systems perform these tasks reliably at scale in production environments. Material gaps remain only in novel or context-specific troubleshooting. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Mature IT automation tools (config management, monitoring, automated backup systems) are deployed widely, but AI-driven troubleshooting of specialized scientific computing environments is still narrow and error-prone in production. |
Create data management or error-checking procedures and user manuals.
59CI 47–70 · exposure 53 · augmentation 88 · importance 3.4/5 · click for rater detail
Create data management or error-checking procedures and user manuals.
59| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics and life sciences organizations are rapidly adopting AI for documentation and procedure generation, with widespread pilot use and growing production deployments of LLM-based tools for technical writing and knowledge management. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Bioinformatics and lab-adjacent technical roles show slower, more cautious AI adoption than fully digital knowledge-work sectors, with pilots for coding assistance more common than adoption for formal documentation/procedure creation. |
| Augmentation potential | claude-haiku-4-5-20251001 | 5/5 | AI excels at assisting technicians by generating initial drafts, organizing content, and catching formatting inconsistencies while humans retain final editorial control, significantly accelerating documentation workflows without removing human judgment. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI coding assistants and writing tools substantially speed up drafting of scripts, checklists, and manual text, letting technicians focus on domain-specific validation and refinement. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | AI can generate substantial portions of data management procedures and user manuals through code analysis and documentation generation; systematic error-checking workflows can be largely automated. However, domain-specific validation and final quality assurance typically require human oversight, limiting full end-to-end automation. |
| Task automatability | claude-sonnet-5 | 3/5 | AI can draft error-checking scripts and user manual text from specs, but designing robust data management procedures for specific bioinformatics pipelines requires domain judgment and validation that current tools cannot fully replace end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Few legal or licensing barriers exist for automating documentation creation; organizations may prefer human review but nothing legally mandates it. Some friction from organizational preference for human-authored technical content, but substitution is readily available. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement mandates a human for this task, though internal quality control, data integrity standards, and institutional review processes create some friction before AI-generated procedures are trusted for production use. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | AI inference costs for generating documentation drafts are substantially lower than the fully-loaded wage of a bioinformatics technician. Integration and light oversight add overhead, but the cost advantage remains significant for routine procedure and manual generation. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | AI-assisted drafting reduces time spent on boilerplate documentation and script scaffolding, but the specialized technician still must verify, test, and integrate procedures, keeping overall cost savings moderate rather than order-of-magnitude. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Products like GitHub Copilot, ChatGPT, and documentation-generation tools reliably produce drafts of procedures and manuals, but the output often requires significant human refinement for technical accuracy and organizational standards. Deployed systems work at scale but with material error rates in specialized bioinformatics contexts. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Code assistants and LLMs can generate draft scripts and documentation, but no deployed product reliably creates validated, production-grade data management/error-checking procedures for bioinformatics workflows without heavy human review. |
Develop or apply data mining and machine learning algorithms.
58CI 38–79 · exposure 50 · augmentation 88 · importance 3.9/5 · click for rater detail
Develop or apply data mining and machine learning algorithms.
58| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Biotech, pharmaceutical, and genomics firms are rapidly adopting ML/AI in research pipelines; AutoML and AI-assisted development tools see widespread pilot and production use in life sciences. Adoption is faster in well-resourced sectors (large pharma, biotech) than in smaller labs, but the trend is decidedly fast and deepening. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Life sciences and bioinformatics are adopting AI/ML tools moderately quickly, with many labs using AI-assisted coding and analysis, though full production-scale replacement of algorithm development is still uneven. |
| Augmentation potential | claude-haiku-4-5-20251001 | 5/5 | AI significantly amplifies bioinformatics technician productivity: large language models and AutoML assistants draft algorithms, suggest features, debug code, and accelerate exploration. The human remains in the loop for interpretation, validation, and problem redefinition, transforming how quickly technicians can prototype and iterate. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI coding assistants, AutoML frameworks, and code-generation tools substantially speed up algorithm prototyping, debugging, and literature-informed model selection for technicians who retain domain oversight. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Current AI systems can automate much of the algorithm development and application pipeline—model selection, hyperparameter tuning, feature engineering, and pipeline construction are now handled by AutoML platforms and large language models. However, domain expertise remains critical for problem framing and validation, so end-to-end autonomy with 50% time-saving is achievable but not universal; some strategic judgment still typically requires human oversight. |
| Task automatability | claude-sonnet-5 | 2/5 | Developing and applying ML/data mining algorithms requires domain judgment, experimental design, and validation against biological ground truth that current AI cannot fully replace end-to-end, though AI can assist coding and pipeline steps. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Minimal regulatory or legal barriers prevent AI deployment for algorithm development and application. The main friction is organizational (validation requirements, internal governance on model governance) and domain expertise gatekeeping, but no licensing requirement or human sign-off mandate exists. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No formal licensing requirement for this technical task, but research integrity, reproducibility standards, and downstream clinical/research validity impose moderate quality-control friction. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 5/5 | Cloud-based ML platforms and open-source AutoML tools offer inference and model training at negligible marginal cost compared to a skilled bioinformatics technician's loaded wage ($60–90k annually), achieving orders of magnitude cost savings per task execution. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI coding tools reduce some development time cheaply, the overall task still requires skilled technician oversight, data curation, and validation, keeping costs closer to comparable rather than dramatically cheaper. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Mature products (AutoML frameworks, AI-assisted coding tools like GitHub Copilot for ML scripts, MLflow, cloud ML services) demonstrably perform algorithm development and application in production at scale across industry and research. Error rates and scope limitations exist in edge cases, but the core task is reliably deployable today. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI coding assistants and AutoML tools exist and are used in bioinformatics workflows, but reliable end-to-end algorithm development for novel biological problems still requires substantial human expertise and validation. |
Develop or maintain applications that process biologically based data into searchable databases for purposes of analysis, calculation, or presentation.
55CI 35–75 · exposure 50 · augmentation 75 · importance 3.8/5 · click for rater detail
Develop or maintain applications that process biologically based data into searchable databases for purposes of analysis, calculation, or presentation.
55| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Bioinformatics is information-sector work in biotech, pharma, and research institutions—all digitally native, heavily funded, and under pressure to scale. Cloud infrastructure and ML-based data pipeline tools are already in production adoption across major life-sciences companies. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Life sciences and bioinformatics groups are adopting AI coding tools gradually, but this is a specialized technical niche within an industry that generally lags behind faster-adopting sectors like finance or general software. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI assists bioinformatics technicians by auto-generating schema, detecting data quality anomalies, suggesting optimizations, and automating routine ETL steps, while humans remain in the loop for validation, decision-making on edge cases, and interpretation of complex biological context. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI coding assistants meaningfully speed up writing, debugging, and documenting code for data pipelines and database schemas, letting technicians focus more on domain-specific logic and validation. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | Most of the data pipeline—ETL, database schema generation, indexing, and query optimization—can be automated with current AI and ML tools. However, domain-specific decisions about biological data validity and interpretation still require human oversight, preventing a full 5. |
| Task automatability | claude-sonnet-5 | 2/5 | AI coding assistants can speed up writing scripts and pipelines for bioinformatics data processing, but building and maintaining full applications integrating domain-specific data models, validation, and database schemas still requires substantial human architecture and domain expertise. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Few regulatory or licensing barriers prevent automation of data processing itself. Data governance and compliance (HIPAA, IRB) are organizational rather than profession-specific; they apply to humans and systems alike. No legal requirement for a human technician to own the automation. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement for this technical development task, but organizational quality control, data integrity requirements, and specialized biological domain knowledge create moderate friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Cloud-based automation (Airflow, Spark, managed databases with AI optimization) costs far less per task-unit than hiring skilled bioinformatics technicians. The human salary for this role is typically $50–80k+, while automated infrastructure and AI services run thousands per year. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | AI coding assistance reduces developer time somewhat, but ongoing maintenance, debugging, and integration with biological data standards still require paid technician/developer time comparable to or exceeding AI tool costs. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Mature tools exist in production (cloud data pipelines, ML-based data quality systems, low-code database platforms) that can handle large-scale bioinformatics data processing. Some custom biological logic still requires human design, but core automation is deployable at scale. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Code-generation tools (Copilot, ChatGPT, Claude) are used in practice to draft scripts and database queries, but no deployed product autonomously develops and maintains full bioinformatics data-processing applications end-to-end reliably. |
Maintain awareness of new and emerging computational methods and technologies.
53CI 42–64 · exposure 42 · augmentation 75 · importance 3.9/5 · click for rater detail
Maintain awareness of new and emerging computational methods and technologies.
53| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 3/5 | Bioinformatics is a digitally native field with early adoption of AI-assisted tools, but most labs still rely on manual journal clubs, conferences, and curated reading rather than delegating awareness entirely to autonomous systems. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Bioinformatics and life sciences are moderately fast adopters of AI research tools, but the sector overall shows mixed digitization and pilot-stage use compared to top adopters like finance or software. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI literature alerts, automated paper summaries, and method tracking systems substantially boost a technician's ability to survey new developments across a wide computational landscape without the technician having to read every abstract manually. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI literature summarization, trend-tracking, and recommendation tools significantly boost a technician's ability to keep up with new computational methods while the human still evaluates and applies findings. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can retrieve and summarize new publications and methods, staying meaningfully aware requires judgment about relevance, quality, and applicability to specific research contexts—something that demands human curation and critical evaluation today. |
| Task automatability | claude-sonnet-5 | 3/5 | AI tools (search, summarization, alerting agents) can surface and summarize new literature and tools, but synthesizing relevance and applicability still requires human judgment, so only partial time savings are realized end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | No regulatory or licensing requirement mandates human-only awareness maintenance; however, organizational practice and the need for expert judgment create modest friction against full automation. |
| Adoption barriers | claude-sonnet-5 | 1/5 | No licensing, liability, or human-contact requirements apply to staying informed about new methods; it's an informal, low-stakes task with no regulatory barrier. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI-assisted literature monitoring (alerts, summaries) is cheap, but the technician's time reviewing and interpreting those outputs remains substantial, and human expertise in filtering signal from noise is hard to replace cost-effectively. |
| Cost vs. human wage | claude-sonnet-5 | 4/5 | AI-based summarization and alerting tools are inexpensive relative to a technician's time spent manually scanning journals and conference proceedings, offering substantial cost savings for the awareness-gathering portion. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Tools like literature mining systems and automated summaries of arxiv/PubMed exist, but they produce high false-positive rates and miss nuanced assessments of method viability; human review remains standard practice for staying current. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Products like AI literature summarizers, research digest tools, and alert systems (e.g., PubMed alerts with AI summarization) are deployed and used, but they are not fully reliable at filtering true emerging significance versus noise. |
Test new or updated software or tools and provide feedback to developers.
52CI 35–70 · exposure 45 · augmentation 75 · importance 3.1/5 · click for rater detail
Test new or updated software or tools and provide feedback to developers.
52| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | Software development and biotech firms with digital infrastructure are rapidly adopting AI-assisted testing and continuous integration pipelines; adoption is accelerating in information-heavy sectors, though smaller or less digitized biotech firms lag behind. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Bioinformatics and scientific computing sectors are moderate adopters of AI tools, with pilots more common than full production deployment of AI-driven software testing. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI excels at assisting humans in testing by automating routine test case generation, execution, and reporting, freeing technicians to focus on exploratory testing, edge-case design, and nuanced domain validation—substantially raising productivity when humans remain in the loop. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI coding assistants can meaningfully help technicians generate test cases, identify bugs, suggest edge cases, and draft feedback reports, significantly speeding up the testing workflow while humans validate domain accuracy. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | AI can automate a substantial portion of software testing through automated test generation, execution, and basic feedback synthesis. However, nuanced evaluation of user experience and complex edge-case discovery may require human oversight, preventing a full 5-point rating despite significant time savings being achievable. |
| Task automatability | claude-sonnet-5 | 2/5 | Software testing requires domain-specific judgment, understanding of biological data pipelines, and nuanced feedback that current AI cannot fully replicate end-to-end, though it can assist with parts like generating test cases or checking outputs. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Few legal or regulatory barriers prevent automation of software testing itself; however, organizations often maintain human testers for quality assurance credibility and domain-specific validation, creating moderate organizational friction rather than hard legal blockers. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No formal licensing requirement exists, but organizational trust in human expert validation for scientific software correctness creates moderate friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Automated testing via AI tools is substantially cheaper than hiring bioinformatics technicians to manually test iteratively, though integration costs and human oversight for validation reduce the advantage below an order of magnitude in some cases. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI can help draft test scripts or flag anomalies cheaply, the specialized domain knowledge needed to evaluate bioinformatics tools means human oversight remains costly, keeping AI only modestly cheaper if at all. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Mature automated testing frameworks and AI-assisted test generation tools exist in production (e.g., cloud-based test automation platforms), but their application to novel bioinformatics tools often requires domain expertise and custom setup; deployment is common in larger tech contexts but less reliable in specialized biotech settings. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI code-testing tools exist but are not widely deployed specifically for bioinformatics software validation, which requires domain expertise in genomics/proteomics data structures and edge cases. |
Monitor database performance and perform any necessary maintenance, upgrades, or repairs.
52CI 38–66 · exposure 42 · augmentation 75 · importance 3.6/5 · click for rater detail
Monitor database performance and perform any necessary maintenance, upgrades, or repairs.
52| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 4/5 | IT and database operations teams in information-intensive sectors (tech, finance, pharma) have widely adopted automated monitoring and self-healing systems; larger organizations deploy these extensively in production environments. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | IT/database operations broadly have moderate AI tooling adoption (AIOps, automated monitoring), but bioinformatics-specific environments in research and healthcare settings adopt more slowly due to specialized infrastructure and smaller vendor ecosystems. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI-driven monitoring dashboards, predictive alerts, and automated remediation recommendations significantly enhance technician productivity by surfacing issues early and suggesting fixes, allowing humans to focus on root-cause analysis and strategic optimization. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI-powered monitoring, anomaly detection, and automated alerting significantly help technicians catch issues faster and prioritize maintenance tasks, meaningfully boosting productivity even though humans remain responsible for actual fixes. |
| Task automatability | claude-haiku-4-5-20251001 | 3/5 | Monitoring database performance through log analysis and alerting systems is largely automatable with current tools (dashboards, anomaly detection), but diagnosis and remediation of complex issues often require domain expertise and context-specific judgment that AI cannot fully replicate without human oversight. |
| Task automatability | claude-sonnet-5 | 2/5 | Routine monitoring can be scripted and alerted via existing tools, but diagnosing performance issues, planning upgrades, and executing repairs on complex bioinformatics databases require human judgment and hands-on system administration that current AI cannot fully replace end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 2/5 | Database maintenance in production systems carries some operational risk (potential downtime, data loss), creating organizational friction and verification requirements, but there is no legal licensing requirement or hard regulatory barrier preventing automation of routine maintenance tasks. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No formal licensing requirement, but organizational risk aversion around data integrity, system uptime, and specialized domain knowledge (genomic databases) creates meaningful friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 4/5 | Automated monitoring and alerting reduce labor cost substantially compared to manual monitoring, though maintenance and repair still require skilled technician oversight; the marginal cost of AI-driven monitoring is very low relative to technician wages. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Monitoring dashboards and alerting are cheap, but the human oversight, troubleshooting, and hands-on repair work still dominate cost, so overall savings versus a technician's wage are modest. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 4/5 | Database monitoring platforms with automated alerting, health checks, and basic remediation are mature and deployed at scale in many organizations; however, complex repairs and optimization decisions still typically require human database administrators to validate and execute. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Database monitoring tools with AI-assisted anomaly detection exist and are deployed in production, but actual maintenance, upgrade execution, and repair work in specialized bioinformatics environments still rely heavily on human DBAs/technicians. |
Participate in the preparation of reports or scientific publications.
48CI 41–55 · exposure 42 · augmentation 75 · importance 3.8/5 · click for rater detail
Participate in the preparation of reports or scientific publications.
48| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 3/5 | Many research institutions and biotech firms are piloting AI writing assistance, but full automation of publication preparation remains uncommon; most current use is augmentative rather than substitutive, reflecting cautious adoption in regulated scientific environments. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Academic and biotech research settings show moderate uptake of AI writing tools for manuscript drafting and editing, though full pipeline integration remains uneven. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI significantly augments productivity by generating initial drafts, organizing data narratives, formatting references, and improving prose clarity, allowing technicians to focus on validating results and integrating domain-specific insights rather than starting from blank pages. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI substantially accelerates drafting, summarizing results, literature review, and formatting, meaningfully boosting productivity while the technician retains responsibility for accuracy and content. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | AI can assist with components like literature review, data visualization formatting, and manuscript structure, but cannot independently produce publication-ready content requiring domain expertise, original analysis interpretation, and scientific judgment. Human expertise remains essential for accuracy and novelty claims. |
| Task automatability | claude-sonnet-5 | 3/5 | AI can draft sections, summarize data, and format citations, saving significant time, but integrating scientific judgment, accurate data interpretation, and coherent narrative still requires substantial human involvement. |
| Adoption barriers | claude-haiku-4-5-20251001 | 3/5 | While no legal requirement mandates human authorship of reports, institutional authorship policies, journal guidelines requiring human accountability, and liability concerns around misrepresentation create moderate friction. Scientific integrity norms also expect human verification of content. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement exists for report writing, but journal policies, authorship norms, and scientific integrity standards create some friction against fully automated content generation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 3/5 | AI inference cost for draft generation is low, but integration into publication workflows and mandatory human review cycles mean total cost per publishable output remains comparable to a technician's time for quality assurance and corrections. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | AI drafting tools are cheap per use, but the need for expert review, fact-checking, and revision by the technician/scientist keeps overall cost savings moderate rather than dramatic. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Products like ChatGPT and specialized writing tools can draft sections and improve clarity in real use, but material weaknesses remain: hallucinated citations, inability to verify methodological claims, and inconsistent adherence to journal-specific standards. Production deployment requires significant human oversight. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | Tools like ChatGPT, Grammarly, and specialized writing assistants are widely used in research settings for drafting and editing, but they still produce errors, hallucinated citations, or misinterpretations requiring careful human review. |
Extend existing software programs, web-based interactive tools, or database queries as sequence management and analysis needs evolve.
44CI 32–55 · exposure 38 · augmentation 75 · importance 3.9/5 · click for rater detail
Extend existing software programs, web-based interactive tools, or database queries as sequence management and analysis needs evolve.
44| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 3/5 | Bioinformatics and research IT sectors show moderate AI tool adoption, with coding assistants increasingly used in development pipelines. However, adoption remains cautious in domains with high correctness and compliance requirements, limiting velocity below information-sector leaders. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | placeholder |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI code generation and completion tools meaningfully augment bioinformatics technicians by accelerating boilerplate and routine extensions, reducing syntax errors, and enabling faster prototyping—while the human retains responsibility for architecture, testing, and validation. |
| Augmentation potential | claude-sonnet-5 | 4/5 | placeholder |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can generate code snippets and assist with routine extensions, evolving software requires understanding complex domain logic, existing architecture, and evolving biological needs—tasks that demand human judgment and testing. Current AI cannot reliably perform this end-to-end with 50% time savings at equal quality without substantial human oversight. |
| Task automatability | claude-sonnet-5 | 3/5 | AI coding assistants can generate and extend code for bioinformatics tools, database queries, and web interfaces, but integrating with existing complex pipelines, domain-specific data formats, and validation requires significant human oversight.','placeholder'.length?1:1, |
| Adoption barriers | claude-haiku-4-5-20251001 | 3/5 | Bioinformatics software often supports regulated research or clinical workflows, creating oversight and liability concerns. Code quality and correctness are critical, and organizations typically require human sign-off on extensions, though no hard licensing barrier prevents AI assistance. |
| Adoption barriers | claude-sonnet-5 | 2/5 | placeholder |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI coding tools reduce development time on straightforward tasks, but the cost of integration, validation, error correction, and ongoing maintenance of complex bioinformatics software remains comparable to or higher than employing a skilled technician due to the high cost of errors. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | placeholder |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Deployed AI coding assistants (GitHub Copilot, etc.) can help with isolated code extensions but lack understanding of proprietary bioinformatics systems, database schemas, and domain-specific validation requirements. Production-grade software maintenance in this domain still requires human developers. |
| Technical feasibility today | claude-sonnet-5 | 3/5 | placeholder |
Design or implement web-based tools for querying large-scale biological databases.
44CI 32–55 · exposure 38 · augmentation 75 · importance 3.9/5 · click for rater detail
Design or implement web-based tools for querying large-scale biological databases.
44| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 3/5 | Bioinformatics and computational biology are moderately digitized sectors with growing adoption of AI coding tools and automated pipelines, but adoption is uneven—many academic labs and smaller organizations lag behind large biotech and pharma. Pilots are common but production-scale AI-driven tool design remains emerging. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Software engineering and bioinformatics R&D sectors are moderately fast adopters of AI coding tools (e.g., Copilot-style assistants), though full tool-building pipelines remain in pilot/exploratory stages. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI coding assistants meaningfully augment human bioinformaticians by accelerating boilerplate, generating query templates, and suggesting schema patterns, allowing humans to focus on domain logic and validation. This demonstrates high augmentation potential while the human remains in control of critical decisions. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI coding assistants substantially speed up writing queries, API integration code, and front-end scaffolding, meaningfully boosting productivity of technicians who retain design and validation control. |
| Task automatability | claude-haiku-4-5-20251001 | 3/5 | Current AI can assist significantly with code generation, database schema design, and web framework scaffolding, but requires substantial human oversight for architecture decisions, security hardening, and validation logic. The task involves both routine coding (automatable) and domain-specific design choices (requiring human judgment), landing at roughly half automatable. |
| Task automatability | claude-sonnet-5 | 2/5 | Designing and implementing full web-based bioinformatics query tools requires architectural decisions, domain-specific schema design, and integration with heterogeneous databases that current AI can assist but not fully automate end-to-end at equal quality.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 3/5 | Some organizational friction exists around trusting AI-generated code for production systems handling sensitive biological data, and data governance policies may restrict full automation. However, no formal licensing requirement prevents AI-assisted or AI-driven implementation, and human oversight is standard practice rather than legally mandated. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No licensing requirement exists for this technical task, but organizational review, data governance, and correctness-critical scientific use create moderate friction against fully autonomous AI deployment. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 3/5 | AI-assisted development reduces per-line development cost and acceleration time, but still requires skilled human bioinformaticians for architecture, validation, and debugging. The cost savings approximate the wages of junior developers but not senior design roles, landing near parity. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI can reduce coding time, the need for skilled human oversight, domain validation, database integration testing, and maintenance keeps all-in costs closer to human-comparable rather than an order of magnitude cheaper. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Code-generation products (GitHub Copilot, Claude) and low-code database tools exist and work in practice, but web tool implementation involves integration complexity, testing, and performance optimization for large-scale data that current AI systems handle incompletely. Products perform parts reliably but with material gaps in end-to-end delivery. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI coding assistants can generate code snippets, boilerplate, and even scaffolding for web apps, but no deployed product reliably builds complete, production-grade bioinformatics database query tools without substantial human engineering and domain oversight. |
Train bioinformatics staff or researchers in the use of databases.
34CI 30–38 · exposure 25 · augmentation 75 · importance 3.1/5 · click for rater detail
Train bioinformatics staff or researchers in the use of databases.
34| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Life sciences and biotech sectors are digitized but conservative on removing human training roles; adoption is limited to supplementary AI-assisted content generation rather than replacement, reflecting slow sector-wide displacement. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Life sciences/bioinformatics is moderately digitized and increasingly uses AI tools for documentation and onboarding, but adoption for formal training delivery remains a pilot-stage activity. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI excels at drafting training materials, generating examples, creating Q&A resources, and personalizing learning paths, significantly raising instructor productivity while trainers retain responsibility for delivery, assessment, and relationship-building. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can significantly assist by generating training materials, FAQs, code examples, and interactive tutorials, boosting trainer productivity even though a human remains central to instruction. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can generate training materials and documentation, end-to-end training requires responsive teaching, assessment of understanding, and adaptive feedback tailored to learner needs—capabilities current systems handle poorly at scale without significant human oversight. |
| Task automatability | claude-sonnet-5 | 2/5 | Training involves live interaction, adapting to learner needs, hands-on demonstration, and answering unpredictable questions, which current AI cannot fully replicate end-to-end at equal quality despite generating some training materials. |
| Adoption barriers | claude-haiku-4-5-20251001 | 3/5 | Organizations typically expect human instructors for compliance, accountability, and learning assurance; regulatory requirements in life sciences contexts may require documented human sign-off on competency, creating moderate friction to full automation. |
| Adoption barriers | claude-sonnet-5 | 2/5 | No formal licensing requirement exists, but institutional preference for expert-led training and the need for trust/credibility with researchers create moderate friction. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI-generated training content has low marginal cost, but the need for human instructors to customize, deliver, assess, and iterate means total automation cost per trainee outcome remains comparable to or higher than direct human instruction. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI can produce tutorials or answer queries cheaply, effective training still requires human oversight, iteration, and troubleshooting, keeping blended costs closer to comparable rather than dramatically cheaper. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | AI can produce tutorial content and answer basic questions, but no deployed system reliably conducts comprehensive staff training with knowledge retention verification and personalized remediation in production settings. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI chatbots and documentation generators exist but no deployed product reliably conducts full staff training on specialized bioinformatics databases in production settings. |
Confer with researchers, clinicians, or information technology staff to determine data needs and programming requirements and to provide assistance with database-related research activities.
29CI 25–32 · exposure 25 · augmentation 63 · importance 3.8/5 · click for rater detail
Confer with researchers, clinicians, or information technology staff to determine data needs and programming requirements and to provide assistance with database-related research activities.
29| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Bioinformatics organizations are adopting AI slowly in this domain. Most adoption focuses on downstream automation (data processing, analysis) rather than upstream requirement-gathering, which remains a bottleneck handled by human technicians. |
| Sector adoption velocity | claude-sonnet-5 | 3/5 | Bioinformatics and research-adjacent settings are moderately fast adopters of AI tools (e.g., LLM-assisted documentation, meeting summarization) but full substitution of consultative roles remains rare in production. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI tools can assist a technician by drafting meeting agendas, auto-generating documentation from transcripts, or suggesting data schema based on stated requirements, meaningfully improving productivity while the technician remains the decision-maker in conferences. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully assist by summarizing meeting notes, drafting requirement documents, suggesting database schemas, and helping translate technical needs, improving technician productivity substantially while human interaction remains central. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | This task requires rich interpersonal communication, contextual judgment about research/clinical needs, and understanding of evolving requirements—capabilities where current AI shows significant limitations. While AI can draft meeting summaries or document specifications, it cannot reliably conduct multi-stakeholder interviews or independently determine complex technical requirements without human oversight. |
| Task automatability | claude-sonnet-5 | 2/5 | This task is fundamentally a live consultative/coordination activity involving eliciting requirements and building rapport across disciplines; AI can support parts (drafting questions, summarizing prior conversations) but cannot conduct the interpersonal negotiation and clarification end-to-end.9, |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Significant organizational and trust barriers exist: researchers and clinicians typically expect direct communication with qualified staff; IT governance often mandates human sign-off on database and security requirements; and regulatory contexts (HIPAA, research ethics) often require documented human accountability. |
| Adoption barriers | claude-sonnet-5 | 3/5 | No strict licensing barrier, but organizational trust, domain expertise credibility, and need for human judgment in interpreting ambiguous research requirements create moderate friction against full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | This task's value lies in domain expertise, listening, and judgment. Automating it would require custom integration, domain-specific training, and careful verification—costs that quickly exceed the loaded hourly wage of a technician performing traditional conferencing and documentation work. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Because a human must still be present to interpret nuanced scientific/clinical needs and build trust, AI mainly supplements rather than replaces this labor, so cost savings are modest rather than order-of-magnitude. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product reliably conducts stakeholder needs assessment and requirements determination autonomously. AI can assist with documentation or data modeling, but conferencing and requirement-gathering in specialized domains (research, clinical, IT infrastructure) remain largely human-driven activities. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | No deployed product autonomously confers with researchers/clinicians to determine data needs; existing tools (chatbots, notetakers) assist meetings but don't replace the technician's active consultative role. |
Confer with database users about project timelines and changes.
26CI 23–30 · exposure 25 · augmentation 50 · importance 3.6/5 · click for rater detail
Confer with database users about project timelines and changes.
26| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Bioinformatics is part of life sciences, a regulated, conservative sector with low current AI adoption for client-facing project management roles. Most organizations still require human technicians to own stakeholder relationships, and adoption of AI conferencing agents remains minimal in production bioinformatics environments. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Bioinformatics and lab-support roles are within life sciences, a sector with slower AI adoption for interpersonal coordination tasks compared to finance or software. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist by drafting email summaries of meetings, suggesting timeline options based on data, or helping organize feedback from multiple users—useful productivity gains for the technician while they retain the relationship and final decision-making authority. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can help draft status updates, summarize project changes, and prepare talking points, offering moderate productivity gains while the technician still leads the actual conferring. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | This task involves interpersonal communication about project coordination, which requires understanding context, stakeholder needs, and negotiating timelines. While AI can draft communications or summarize discussions, it cannot reliably conduct the full back-and-forth dialogue to reach agreements on complex project changes without human judgment and domain expertise. |
| Task automatability | claude-sonnet-5 | 2/5 | This is a relationship-driven communication task requiring real-time negotiation and judgment about priorities; AI can assist but cannot fully replace the human interaction end-to-end.- |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Strong barriers exist: stakeholders typically expect human contact for project decisions, there is organizational friction around delegating client-facing communications to AI, and reputational/relationship risk creates implicit liability if conferencing is fully automated and errors occur in project commitments. |
| Adoption barriers | claude-sonnet-5 | 3/5 | No licensing requirement, but organizational trust, domain expertise needs, and preference for human accountability in project communications create moderate friction. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | A bioinformatics technician's conferencing role is relatively low-cost per hour compared to senior roles. AI systems would still require significant human oversight and correction for miscommunications, making the all-in cost (infrastructure, integration, human review) comparable to or possibly higher than the direct human wage. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Human technicians already handle this as part of broader duties at low incremental cost; AI tools would add integration overhead without clearly reducing total cost for this specific interpersonal task. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Current AI chatbots and agents can simulate conversation but lack reliable real-world deployment for genuine stakeholder conferencing with accountability for decisions. Products exist for scheduling and basic project communication, but none demonstrate reliable end-to-end performance in actual bioinformatics project negotiations where accuracy and relationship-building matter. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Chatbots and scheduling assistants exist for status updates, but no deployed product reliably manages nuanced stakeholder conversations about scientific project scope changes in production. |
Related occupations — Computer & Mathematical
How to read this
A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.
What would change this score
New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.